Daily Judi: Tuesday, September 27, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Genentech's Ashish Pradhan, M.D., discusses moving away from a “one size fits all” approach in how it develops treatments for patients. (Fierce Biotech)
Faced with a shortage, the United States Food and Drug Administration (FDA) approved more allotments of Moderna's COVID-19 booster. (Reuters)
Meanwhile, intended to encourage pediatric studies, the FDA has published ethical guidelines and protections on including children in clinical trials. (Pharmaphorum)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
"The Judi platform is purpose-built to drive clinical trial success—cloud-based, secure, collaborative. Our greatest strength, above all else, is our people."
–Abraham Gutman, President & CEO
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.